January 22nd, 2007
New Drug Erbitux® Prolongs Lives of Head and Neck Cancer Patients
Preliminary findings of a new study designed by researchers at the University of Maryland Medical Center found that adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer to live longer.
According to Mohan Suntharalingam, M.D., lead author of the study and a radiation […]
Recent Comments